QUOTE AND NEWS
SeekingAlpha  Sep 16  Comment 
By Adam Gefvert, CFA: Achillion Pharmaceuticals (NASDAQ:ACHN) is a biotech company that focuses on developing treatments for Hepatitis C (HCV). Most of the company's value is riding on the success of its nucleotide, ACH-3422. Research suggests...
Benzinga  Sep 15  Comment 
NPS Pharmaceuticals (NASDAQ: NPSP) fell 10.70% to $29.20 in pre-market trading. The FDA has voted 8-5 in favor of NPS Pharmaceuticals' Natpara. Achillion Pharmaceuticals (NASDAQ: ACHN) shares slipped 3.28% to $11.78 in pre-market trading after...
Benzinga  Sep 12  Comment 
Health Care REIT (NYSE: HCN) fell 3.62% to $64.08 in pre-market trading after the company announced a proposed offering of 15.5 million shares of common stock. Achillion Pharmaceuticals (NASDAQ: ACHN) shares slipped 3.47% to $12.23 in pre-market...
SeekingAlpha  Sep 8  Comment 
By Small Pharma Analyst: A few months ago, Merck (NYSE:MRK) surprised investors by acquiring Idenix (NASDAQ:IDIX) for $3.85 billion, a 239% premium to its closing share price of the prior day. This was an unexpected acquisition, since most thought...
TheStreet.com  Sep 5  Comment 
BOSTON (TheStreet) -- An email from Roman W. about Achillion Pharmaceuticals kicks off this week's Biotech Stock Mailbag. Roman asks, "Adam, in your latest articles discussing the important biotech events for the rest of the year, I noticed...
StreetInsider.com  Sep 3  Comment 
52-Week High: Mobileye N.V (NYSE: MBLY) $49.44. Mobileye rising today following positive comments from Morgan Stanley. The firm sees Mobileye potentially reaching $100 per share, based on key factors like average selling price, margins, market...
Benzinga  Sep 3  Comment 
Infinity Pharmaceuticals (NASDAQ: INFI) jumped 46.43% to $15.99 on deal with AbbVie (NYSE: ABBV). Yandex NV (NASDAQ: YNDX) jumped 3.92% to $30.20 in pre-market trading after gaining 2.22% on Tuesday. Navistar International (NYSE: NAV) shares...
SeekingAlpha  Sep 3  Comment 
By SA Editor Miriam Metzinger: Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday September 2. Bullish Calls: Complete Story ยป
Benzinga  Sep 2  Comment 
Compuware (NASDAQ: CPWR) jumped 16.15% to $10.86. According to the Wall Street Journal, Compuware is in talks to sell itself to a private equity firm. Achillion Pharmaceuticals (NASDAQ: ACHN) shares gained 3.54% to $11.98 in pre-market trading...
FierceBiotech  Aug 27  Comment 
Ted Tenthoff, an analyst for Piper Jaffray, was clearly pumped about the prospects of an Achillion buyout when a reporter from Bloomberg reached him.





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki